Neurogene (NGNE) traded down -0.04 % during a 24 hours period ending at 10:15 AM Central Europe on Tuesday 27th. One Neurogene stock can currently be bought for about USD 23.54 on popular exchanges. Current supply of Neurogene stocks is 20 mn. Neurogene has a current market capitalization of USD 488.7 mn and approximately USD 2.9 mn worth of Neurogene was traded on exchanges in the last 24 hours. Since last month end, Neurogene has traded -17.35 % down. Simple moving average of last 200 days is at USD 27.6. The highest price of past 52 weeks was recorded at USD 43.66 on 07/09/2026. 52 weeks low was at USD 15.93 on 02/05/2026.
Here is how related stocks have performed in the past 24 hours:
Climb Bio (CLYM) traded down -13.54 % and now trades at USD 8.81. Current market capitalisation for Climb Bio is USD 585.3 mn.
Ironwood (IRWD) traded up 1.16 % and now trades at USD 3.5. Ironwood has a market capitalisation of USD 578.3 mn. Current price/earnings ratio for Ironwood is 4.37.
Cars (CARS) traded down -1.55 % and now trades at USD 10.77. Current market capitalisation for Cars is USD 578.2 mn. Cars has a current price to earnings ratio of 19.06.
Gmr (GMRS) traded up 0.75 % and now trades at USD 10.81. Current market capitalisation for Gmr is USD 584 mn.
Zevra Therapeutics (ZVRA) traded down -2.85 % and now trades at USD 9.53. Current market capitalisation for Zevra Therapeutics is USD 585.5 mn. Zevra Therapeutics has a current price to earnings ratio of 10.26.
About Neurogene
Neurogene Inc. is a biopharmaceutical company that specializes in developing genetic medicines for individuals and their families affected by severe neurological diseases. Based in New York, United States, the company serves customers globally through its website at www.neurogene.com and trades on the Nasdaq stock exchange. The IPO of the company took place on March 7, 2014.
